Enzo Biochem, Inc. (ENZ)
Largest Insider Buys in Sector
ENZ Stock Price History Chart
ENZ Stock Performance
About Enzo Biochem, Inc.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, …
Insider Activity of Enzo Biochem, Inc.
Over the last 12 months, insiders at Enzo Biochem, Inc. have bought $0 and sold $0 worth of Enzo Biochem, Inc. stock.
On average, over the past 5 years, insiders at Enzo Biochem, Inc. have bought $261,776 and sold $2.09M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $12,875 was made by Wolf James G. () on 2023‑02‑13.
List of Insider Buy and Sell Transactions, Enzo Biochem, Inc.
| 2023-02-13 | 10,000 0.0208% | $1.29 | $12,875 | +10.83% | ||||
| 2023-02-10 | 5,000 0.0103% | $1.29 | $6,450 | +9.30% | ||||
| 2023-01-27 | director | 11,800 0.024% | $1.40 | $16,520 | 0.00% | |||
| 2022-11-23 | Chief Executive Officer | 100,000 0.2052% | $1.97 | $197,000 | -24.37% | |||
| 2022-11-01 | director | 8,500 0.0172% | $2.14 | $18,225 | -28.57% | |||
| 2022-10-31 | director | 14,500 0.0299% | $2.15 | $31,175 | -27.57% | |||
| 2022-07-15 | Chief Operating Officer | 2,500 0.0052% | $2.42 | $6,050 | -9.17% | |||
| 2022-07-12 | 12,500 0.0243% | $2.27 | $28,375 | -9.17% | ||||
| 2022-07-05 | 120,000 0.2362% | $2.20 | $264,000 | -4.78% | ||||
| 2022-06-15 | 75,000 0.1523% | $2.20 | $165,000 | -1.35% | ||||
| 2022-06-15 | Chief Executive Officer | 4,600 0.0093% | $2.19 | $10,074 | -1.35% | |||
| 2022-06-14 | Chief Financial Officer | 3,500 0.0074% | $2.15 | $7,525 | +4.76% | |||
| 2021-03-16 | Sale | 10 percent owner | 300,000 0.706% | $4.65 | $1.39M | -19.61% | ||
| 2021-03-15 | Sale | 10 percent owner | 144,768 0.4879% | $4.83 | $698,840 | +10.81% | ||
| 2020-02-18 | 10 percent owner | 4,000 0.0082% | $2.20 | $8,800 | +7.14% | |||
| 2020-02-14 | 10 percent owner | 6,000 0.0125% | $2.21 | $13,260 | +7.66% | |||
| 2019-08-20 | 10 percent owner | 9,700 0.0202% | $3.11 | $30,167 | -16.24% | |||
| 2019-08-16 | 10 percent owner | 22,800 0.0456% | $3.06 | $69,768 | -18.32% | |||
| 2019-07-23 | 10 percent owner | 409,200 0.87% | $3.65 | $1.49M | -24.93% | |||
| 2019-07-22 | 10 percent owner | 9,644 0.0201% | $3.64 | $35,104 | -26.36% |
Insider Historical Profitability
| HARBERT MANAGEMENT CORP | 10 percent owner | 5175913 9.9072% | $0.97 | 8 | 2 | <0.0001% |
| Radoff Bradley Louis | 4194663 8.029% | $0.97 | 3 | 0 | <0.0001% | |
| Wolf James G. | 4100000 7.8478% | $0.97 | 5 | 0 | <0.0001% | |
| RABBANI ELAZAR | Chm of the Bd, CEO and Sec | 1848668 3.5385% | $0.97 | 2 | 3 | +1.13% |
| RABBANI SHAHRAM K | Treasurer, Secretary | 1828494 3.4999% | $0.97 | 1 | 5 | <0.0001% |
Institutional Investor Ownership
| HARBERT FUND ADVISORS, INC. | $6.57M | 10.06 | 5.18M | 0% | +$0 | 4.77 | |
| Renaissance Technologies | $3.09M | 4.73 | 2.44M | -1.78% | -$55,970.81 | 0.01 | |
| The Vanguard Group | $2.38M | 3.65 | 1.88M | 0% | +$0 | <0.0001 | |
| Tang Capital Management, LLC | $1.6M | 2.45 | 1.26M | -25.88% | -$558,783.66 | 0.01 | |
| BlackRock | $1.21M | 1.85 | 953,991 | +0.03% | +$411.48 | <0.0001 |